Prospective multicenter clinical evaluation of AMPLICOR and COBAS AMPLICOR hepatitis C virus tests

Journal of Clinical Microbiology

Volumn 39, Issue 11, 2001, Pages 4005-4012

  Nolte, F S ^a   Fried, M W ^a   Shiffman, M L ^a   Ferreira Gonzalez, A ^a   Garrett, C T ^a   Schiff, E R ^a   Polyak, S J ^a   Gretch, D R ^a  

^a EMORY UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ADOLESCENT; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CLINICAL TRIAL; DEVICE; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC TEST; EVALUATION; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HISTOLOGY; HUMAN; INTERMETHOD COMPARISON; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NONHUMAN; PERFORMANCE; PLASMA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RELIABILITY; REPRODUCIBILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; SEROLOGY; SERUM; UNITED STATES; VIRUS DIAGNOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; FEMALE; HEPACIVIRUS; HEPATITIS C; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL;

HEPATITIS C VIRUS; RNA VIRUSES;

EID: 0034764239     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.39.11.4005-4012.2001     Document Type: Article

References (20)

1. Importance of primer selection for the detection of hepatitis C virus RNA with the polymerase chain reaction assay
2. Sequence analysis of the core gene of 14 hepatitis C virus genotypes
3. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease
4. International collaborative study on the second EUROHEP HCV-RNA reference panel
5. Second generation of the automated Cobas Amplicor HCV assay improves sensitivity of hepatitis C virus RNA detection and yields results that are more clinically relevant
6. Diagnosis and monitoring of hepatic injury. II. Recommendations for use of laboratory tests in screening, diagnosis, and monitoring
7. EASL International Consensus Conference on Hepatitis C. Paris, 26-28, February 1999, Consensus statement
8. Natural fluctuations of hepatitis C viral load in the homogeneous patient population: A prospective study
9. Blood screening by nucleic acid amplification technology: Current issues, future challenges
10. Detection of hepatitis C virus RNA: Comparison of one-stage polymerase chain reaction (PCR) with nested-set PCR
11. Use of aminotransferase, hepatitis C antibody, and hepatitis C polymerase chain reaction RNA assays to establish the diagnosis of hepatitis C virus infection in a diagnostic virology laboratory
12. Quantitation of hepatitis C virus RNA in serum of asymptomatic blood donors and patients with type C chronic liver disease
13. Improved version 2.0 qualitative and quantitative AMPLICOR reverse transcription-PCR tests for hepatitis C virus RNA: Calibration to international units, enhanced genotype reactivity, and performance characteristics
14. Use of uracil DNA glycosylase to control carry-over contamination in polymerase chain reactions
15. National Institutes of Health Consensus Development Conference Panel Statement: Management of hepatitis C
16. Detection of residual hepatitis C virus RNA by transcription-mediated amplification of patients with complete virologic response according to polymerase chain reaction-based assays
17. Multigene tracking of hepatitis C virus quasispecies after liver transplantation: Correlation of genetic diversification in the envelope region with asymptomatic or mild disease patterns
18. Comparison of HCV RNA assays for the detection and quantification of hepatitis C virus RNA levels in serum of patients with chronic hepatitis C treated with interferon
19. Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection
20. Quantification of the initial decline of serum hepatitis C virus RNA and response to interferon alfa